Sunrise Financial Services’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26
Closed -$455 653
2026
Q1
$455 Buy
+26
New +$501 ﹤0.01% 563

Other funds holding BIOA

Sunrise Financial Services's BIOA Position: Q2 2026 in Review

Sunrise Financial Services sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 26 shares — an estimated $455 sold.

Sunrise Financial Services first reported a position in BIOA in Q1 2026 and held it in 1 quarter. The position peaked at $455 in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Sunrise Financial Services reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
  • Sunrise Financial Services sold 26 BioAge Labs shares in Q2 2026, an estimated $455.
  • Sunrise Financial Services first reported a position in BioAge Labs in Q1 2026 and held it in 1 quarter.
  • Sunrise Financial Services's BioAge Labs position peaked at $455 in Q1 2026.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Sunrise Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.